Bibliographies thématiques / Pharmaceutical biotechnology – Law and legislation

Sommaire

Articles de revues
Thèses
Livres
Chapitres de livres
Actes de conférences

Littérature scientifique sur le sujet « Pharmaceutical biotechnology – Law and legislation »

Auteur : Grafiati

Publié le 10 mars 2023

Mis à jour le 19 juillet 2025

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Pharmaceutical biotechnology – Law and legislation ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Articles de revues sur le sujet "Pharmaceutical biotechnology – Law and legislation"

Omelchenko, Olha. "Some aspects of the intellectual property legislation development to expand access to biotechnology medicines." Theory and Practice of Intellectual Property, no. 1 (March 18, 2025): 97–104. https://doi.org/10.33731/12025.325004.

Texte intégral

Résumé :

The article examines the legal aspects of intellectual property and their impact on access to biotechnology medicines, considering prospects for legislative reform. The author analyzes legal mechanisms for ensuring access to medicines and their implementation in national legislation. Key priorities and reform prospects in intellectual property and pharmaceutical legislation are identified, addressing the challenges of martial law, European integration commitments, and the need to eliminate barriers to the timely market entry of generics and biosimilars. Intellectual property rights are a valua

Styles APA, Harvard, Vancouver, ISO, etc.

Del CASTILLO Rodríguez, Carlos. "PHARMACEUTICAL LEGISLATION OR PHARMACEUTICAL LAW? ANALYSIS." Vitae 18, no. 1 (2011): 83–87. http://dx.doi.org/10.17533/udea.vitae.8771.

Texte intégral

Résumé :

After legal enaltment in the pharmaceutical profession appear two intimately related concepts: the pharmaceutical law andt the pharmaceutical legislation that we should define and analyze. On the one hand, the pharmaceutical law is a heterogeneous group of dispositions regulating directly or indirectly the pharmaceutical activity. It cannot be considered an independent branch of the law, but it is possible for practical effects to order systematically the legal regulations. Such is the source of a new branch inside the sanitary law, the pharmaceutical legislation, that every pharmacies most kn

Styles APA, Harvard, Vancouver, ISO, etc.

Ivanenko, Dmytro, and Nataliia Hlushchenko. "LEGAL ASPECTS OF INTELLECTUAL PROPERTY IMPACT ON AVAILABILITY OF MEDICINES IN UKRAINE." Law Journal of Donbass 76, no. 3 (2021): 39–44. http://dx.doi.org/10.32366/2523-4269-2021-76-3-39-44.

Texte intégral

Résumé :

The right of a person to access medicines is derived from the right to health. At the time of the establishment of fundamental human rights, the issue of lack of access to medical supplies was not considered a violation of human rights. The spread of pandemics has led to the gradual recognition of the right of access to medicines. The TRIPS agreement fundamentally reformatted the discussion on access to medicines. Prior to the TRIPS Agreement, states had considerable independence in the formation and implementation of state policy in the field of intellectual property. TRIPS obliges countries

Styles APA, Harvard, Vancouver, ISO, etc.

Omelchenko, Olha. "Intellectual property rights in the context of biology, medicine and pharmacy: a look into the future." Theory and Practice of Intellectual Property, no. 3 (June 19, 2023): 109–17. http://dx.doi.org/10.33731/32023.282330.

Texte intégral

Résumé :

The article covers the study of some aspects of protecting the intellectual property rights in the areas of biology, medicine and pharmacy including biotechnological inventions. The rapid progress of science and technology, the generation and accumulation of knowledge, the possibilities to process large amounts of various data further stimulate the development of all social areas and unprecedentedly contribute to the emergence of innovations, in particular in the area of biotechnology. Intellectual property rights have a direct impact on the progress of medical and biological research, but inc

Styles APA, Harvard, Vancouver, ISO, etc.

Holman, Christopher M. "Congress Considering Legislation Aimed at Increasing Competition in Pharmaceuticals." Biotechnology Law Report 38, no. 3 (2019): 144–53. http://dx.doi.org/10.1089/blr.2019.29125.cmh.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Albolino, Sara, Tommaso Bellandi, Simone Cappelletti, et al. "New Rules on Patient’s Safety and Professional Liability for the Italian Health Service." Current Pharmaceutical Biotechnology 20, no. 8 (2019): 615–24. http://dx.doi.org/10.2174/1389201020666190408094016.

Texte intégral

Résumé :

Background:The phenomenon of clinical negligence claims has rapidly spread to United States, Canada and Europe assuming the dimensions and the severity of a pandemia. Consequently, the issues related to medical malpractice need to be studied from a transnational perspective since they raise similar problems in different legal systems.Methods:Over the last two decades, medical liability has become a prominent issue in healthcare policy and a major concern for healthcare economics in Italy. The failures of the liability system and the high cost of healthcare have led to considerable legislative

Styles APA, Harvard, Vancouver, ISO, etc.

SEREBRENNIKOVA, ANNA. "PHARMACEUTICAL LAW: CRIMINAL ASPECTS." Gaps in Russian Legislation 14, no. 6 (2021): 203–9. http://dx.doi.org/10.33693/2072-3164-2021-14-6-203-209.

Texte intégral

Résumé :

The author, considering the possibility of the emergence of a new branch of law in the future - pharmaceutical law, focuses on the complexity of regulating the sphere of turnover of medicines, at the same time pointing to this as the main reason for the uncertainty of the legislator in matters of the correctness of the choice of the object and subject of legal regulation. The author, citing examples from practice, draws attention to the fact that pharmaceutical activity is gradually becoming the object of regulatory regulation of various legal institutions, where the turnover of medicines, as

Styles APA, Harvard, Vancouver, ISO, etc.

Frolova, O. "Implementation of EU legislation into the criminal legislation of Ukraine to ensure criminal legal protection of pharmaceutical activity." Scientific and informational bulletin of Ivano-Frankivsk University of Law named after King Danylo Halytskyi, no. 16(28) (December 13, 2023): 176–83. http://dx.doi.org/10.33098/2078-6670.2023.16.28.176-183.

Texte intégral

Résumé :

The purpose of the article is to determine the specifics of the implementation of EU legislation into the criminal law of Ukraine to ensure the criminal protection of pharmaceutical activity. The methodology includes the author's emphasis on basic international legal guidelines. Directive No. 2001/83/EC of the European Parliament and the Council of the EU on the Community Code on Medicinal Products for Human Use of November 6, 2001 serves as one of the main guidelines here. In the author's opinion, this is important based on the fact that the adopted Law of Ukraine "On Medicinal Products" of J

Styles APA, Harvard, Vancouver, ISO, etc.

Malinowski, Michael J. "Pharmaceutical Medicine, Biotechnology and European Law." Journal of Legal Medicine 23, no. 1 (2002): 159–66. http://dx.doi.org/10.1080/019476402317276722.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Noguera Peña, Alfonso, and Carlos del Castillo Rodríguez. "Pharmaceutical Law and Pharmaceutical Legislation in Spain and in the European Union: Concept, Evolution and Sources." Anales de la Real Academia Nacional de Farmacia 87, no. 87(03) (2021): 275–322. http://dx.doi.org/10.53519/analesranf.2021.87.03.06.

Texte intégral

Résumé :

Medicines and the professional activity of the pharmacists are the subject of study of Pharmaceutical Law and Pharmaceutical Legislation. In this paper, on the one hand, the definition of these disciplines is examined, as well as their field of study, evolution and sources. On the other hand, the development of Pharmaceutical Legislation in the European Union is analysed in three clearly differentiated periods and related to different juridic enactments of generations of norms that affect medicines. Special attention has been paid to the so–called third generation standards, as the regulatory

Styles APA, Harvard, Vancouver, ISO, etc.

Plus de sources

Thèses sur le sujet "Pharmaceutical biotechnology – Law and legislation"

Babin, Dominique. "The Canadian pharmaceutical patent regime in the world trading system /." Thesis, McGill University, 1999. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=29957.

Texte intégral

Résumé :

In 1994, the members of the World Trade Organisation (WTO) adopted the Agreement on Trade-Related Aspects of Intellectual Property (the "TRIPs Agreement") and thus committed themselves to respect certain standards for intellectual property protection. This thesis studies the scope of the standards for patent protection and their impact upon trade in medicines. The first part addresses the international dimension of the issue and explains how international trade in medicines can contribute to enhancing the level of global welfare. The first chapter argues that in order to fulfil this latter obj

Styles APA, Harvard, Vancouver, ISO, etc.

Vazquez, Toro Guillermo J. "Patent Quality And Company Performance| A Sample within the USA Biotechnology and Pharmaceutical Industry." Thesis, Inter-American University of Puerto Rico (Puerto Rico), 2014. http://pqdtopen.proquest.com/#viewpdf?dispub=3577982.

Texte intégral

Résumé :

<p> This Dissertation investigates the relationship between patent quality and company performance for a sample from the US Biotechnology and Pharmaceutical Industry. The methodology devised comprehensively examines patent worth (patent’s references), patent protection (claims and family patents) and patent quality (references, claims and family patents) to determine their implications on firm leverage (SE, TA), profits (ROE, ROA), and market value (B/M, MCap). The selected sample comprises 1,536 companies, and 285,000 patents from 1999 to 2009. The results show that total revenue just r

Styles APA, Harvard, Vancouver, ISO, etc.

Stoddard, Damon. "A new Canadian intellectual property right : the protection of data submitted for marketing approval of pharmaceutical drugs." Thesis, McGill University, 2006. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=101828.

Texte intégral

Résumé :

In order to market and sell a new pharmaceutical drug in Canada, the Minister of Health requires the initial applicant to submit clinical test results demonstrating that the drug is safe and effective for human use. Subsequent applicants, who typically lack the resources to conduct expensive clinical trials, must refer to and rely upon the initial applicant's data in their applications to market a generic version of the drug.<br>On June 17, 2006, the federal government of Canada published a proposed data protection regulation, which would provide an initial applicant with eight years of protec

Styles APA, Harvard, Vancouver, ISO, etc.

Ludlow, Karinne Anne. "Which little piggy to market? : legal challenges to the commercialisation of agricultural genetically modified organisms in Australia." Monash University, Faculty of Law, 2004. http://arrow.monash.edu.au/hdl/1959.1/5489.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Griffiths, Robert Ian. "Industrial drug development : application of the theoretical framework of Abernathy, Clark, and Kantrow (1983) in an analysis of factors which determine productivity /." Thesis, This resource online, 1988. http://scholar.lib.vt.edu/theses/available/etd-04122010-083717/.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Zeitoun, Suzanna. "Are legislators able to meet efficiency goals? : an analysis of the pharmaceutical industry." Thesis, Linköping University, Department of Management and Economics, 2004. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-2443.

Texte intégral

Résumé :

<p>During the last decades, legislators have tried to meet the goal of increased R&D in the pharmaceutical industry through an extension of the patent length. In parallel, an attempt to minimise ex post social costs has been made through the introduction of a shortened drug approval process for generic drugs as well as a so-called Bolar provision, giving generic producers earlier access to patented information. However, one can ask how efficient a patent extension possibility has been to meet the goal of increased R&D. Correspondingly, what effects on social costs can we expect from the introd

Styles APA, Harvard, Vancouver, ISO, etc.

Letsitsi, Ezekiel Tebogo. "Waste management in the pharmaceutical industry : an evaluation report of Dr Reddy's Laboratories." Thesis, Rhodes University, 2013. http://hdl.handle.net/10962/d1001872.

Texte intégral

Résumé :

The pharmaceutical industry must worry about managing pharmaceutical waste as it poses a health risk to human beings and its presence in the environment can also contribute to loss of biodiversity. Ngwuluka, Ochekpe, and Odumosu (2011: 11259) state that “Pharmaceuticals, though used to treat and manage diseases, are poisons, which justify the growing concerns about their presence in the environment.” Various forms of pharmaceutical waste exist, Ngwuluka et al. (2011) identified the following forms of pharmaceutical waste: Expired dosage forms, non-reworkable formulations, spilled pharmaceutica

Styles APA, Harvard, Vancouver, ISO, etc.

蘇柏昇. "澳門藥事法規修訂及其對公立醫院藥品供應的影響研究". Thesis, University of Macau, 2010. http://umaclib3.umac.mo/record=b2454949.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Périé-Frey, Sarah. "Essai sur l'émergence d'un régime juridique autonome du médicament : entre bien public et bien marchand : Regards croisés en droit interne et en droit de l'Union européenne." Thesis, Perpignan, 2017. http://www.theses.fr/2017PERP0006/document.

Texte intégral

Résumé :

Comme tout corps de règles naissant et se constituant progressivement en système juridique spécifique, les règles applicables au médicament se nourrissent des régimes juridiques externes préexistants que ceux-ci relèvent du droit public ou du droit privé. Dans les systèmes juridiques reconnus, les emprunts faits, une logique d'appropriation se met en place qui aboutit à la transformation et la spécialisation de la règle empruntée à l'objet ou la situation spécifiquement abordée. Les règles applicables au médicament parviennent-elles effectivement, suivant ce processus classique, à s'approprier

Styles APA, Harvard, Vancouver, ISO, etc.

Msomi, Zuziwe Nokwanda. "The protection of indigenous knowledge within the current intellectual property rights regime: a critical assessment focusing upon the Masakhane Pelargonium case." Thesis, Rhodes University, 2013. http://hdl.handle.net/10962/d1007744.

Texte intégral

Résumé :

The use of indigenous knowledge (IK) and indigenous bio-resources by pharmaceutical and herbal industries has led to concerns about the need to protect IK in order to prevent biopiracy and the misappropriation of indigenous knowledge and resources. While some commentators believe that intellectual property rights (IPR) law can effectively protect IK, others are more sceptical. In order to contribute to the growing debate on this issue, this study uses the relatively new and as yet largely critically unanalysed Masakhane Pelargonium case to address the question of whether or not IPR law can be

Styles APA, Harvard, Vancouver, ISO, etc.

Plus de sources

Livres sur le sujet "Pharmaceutical biotechnology – Law and legislation"

Cook, T. M. Pharmaceuticals, biotechnology & the law. Macmillan, 1991.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Wegner, Harold C. Patent law in biotechnology, chemicals & pharmaceuticals. Stockton Press, 1992.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Barr, David K., and Daniel L. Reisner. Developments in pharmaceutical and biotech patent law 2013. Practising Law Institute, 2013.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

1942-, Chiu Yuan-yuan H., and Gueriguian John L, eds. Scientific and regulatory aspects of drug biotechnology. M. Dekker, 1991.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

H, Chiu Yuan-yuan, and Gueriguian John L, eds. Drug biotechnology regulation: Scientific basis and practices. M. Dekker, 1991.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Barr, David K., and Daniel L. Reisner. Developments in pharmaceutical and biotech patent law 2009. Practising Law Institute, 2009.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Barr, David K., and Daniel L. Reisner. Developments in pharmaceutical and biotech patent law 2010. Practising Law Institute, 2010.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Barr, David K., and Daniel L. Reisner. Developments in pharmaceutical and biotech patent law 2012. Practising Law Institute, 2012.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Mo.) Biotechnology Roundtable (5th 2003 Saint Louis. Fifth Biotechnology Roundtable: "Biopharming and Biosafety". ABA Section of Environment, Energy, and Resources, 2003.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Geigert, J. The challenge of CMC regulatory compliance for biopharmaceuticals. Kluwer Academic/Plenum Publishers, 2004.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Plus de sources

Chapitres de livres sur le sujet "Pharmaceutical biotechnology – Law and legislation"

Cazzaniga, Simona. "Medicine Packaging Legislation and Its Evolution According to Technological Innovation for Better Healthcare Support." In Research for Development. Springer Nature Switzerland, 2024. https://doi.org/10.1007/978-3-031-53294-8_2.

Texte intégral

Résumé :

AbstractIf directives, laws, and regulations play a fundamental role in constraining the pharmaceutical sector’s production, distribution and communication policies and practices, regulatory devices have also had and are also playing a role in incentivising innovation and orienting it towards socially and environmentally sustainable practices. The chapter builds a review of the principal regulations that, starting from the EU level, are raising awareness in the various countries of the community (here, the Italian case is analysed) towards the issues of the environment (e.g., reduction of the source of packaging materials and redesigning the pack by favouring the use of recyclable materials), traceability for anti-counterfeiting purposes; safety; and the ethics of medicine communication both in advertising and online. The regulatory review constitutes a starting point, deepened in other chapters, through the review of guidelines, recommendations, and soft law tools, to which those involved in design and innovation activities in the sector must refer.

Styles APA, Harvard, Vancouver, ISO, etc.

"Table of treaties, European legislative instruments and national legislation." In Pharmaceutical Medicine, Biotechnology and European Law. Cambridge University Press, 2001. http://dx.doi.org/10.1017/cbo9780511560125.004.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

"Indirect Infringement." In Pharmaceutical, Biotechnology and Chemical Inventions, edited by Duncan Bucknell. Oxford University PressOxford, 2011. https://doi.org/10.1093/9780199289011.003.0046.

Texte intégral

Résumé :

Abstract This chapter discusses indirect infringement, which may occur as a result of supply of a non-patented product for an infringing use (sometimes referred to as ‘contributory infringement’) or actions constituting inducement (or procurement) of another party directly to infringe. Most of the jurisdictions dealt with in this text have codified that in certain circumstances, supply of a product which is not itself patented is an act of infringement. Interestingly, the Canadian and Italian patent legislation do not specifically deal with contributory infringement and it is left to the common law. The extent to which the geographical boundary of a jurisdiction impinges on supply of non-patented products also varies. In France, Germany, the Netherlands, and the United Kingdom, supply of ‘staple commercial products’ or ‘means generally available in the trade’ is usually a blanket exception to contributory infringement. A similar exclusion exists in Australia, Japan, and the United States for ‘staple commercial products’.

Styles APA, Harvard, Vancouver, ISO, etc.

Grubb, Philip W., Peter R. Thomsen, Tom Hoxie, and Gordon Wright. "Patents and Competition Law—United Kingdom and European Union." In Patents for Chemicals, Pharmaceuticals, and Biotechnology. Oxford University Press, 2016. http://dx.doi.org/10.1093/oso/9780199684731.003.0029.

Texte intégral

Résumé :

This chapter focuses on competition law in the UK and EU. Most countries, as well as the EU, have developed a body of competition law to provide countermeasures against what are regarded as abuses of monopoly by patentees. Abuse of monopoly is the use of a patent simply to exclude others, while not working the invention oneself. Provisions of the Paris Convention enable compulsory licences to be granted if the patent is not worked within a certain time. In the UK, they may also be granted if the patentee is preventing the working of a dependent patent by refusing to grant a licence. In the EU, competition law for the internal common market is within the exclusive competence of EU institutions; the national governments of member states only assist these institutions when it comes to implementation of the legislation. The remainder of the chapter explains EU patent licence agreements.

Styles APA, Harvard, Vancouver, ISO, etc.

"The Agricultural Chemicals Regulatory Approval Process." In Pharmaceutical, Biotechnology and Chemical Inventions, edited by Duncan Bucknell. Oxford University PressOxford, 2011. https://doi.org/10.1093/9780199289011.003.0070.

Texte intégral

Résumé :

Abstract This chapter outlines the regulatory frameworks for agricultural chemicals and veterinary medicines in Australia, China, India, Japan, the United States, and the European Union, each operating under distinct legislative structures. It Australia’s Agricultural and Veterinary Chemicals Code 1994 and the role of the Australian Pesticides and Veterinary Medicines Authority (APVMA) under the National Registration Scheme. It also describes how China requires Ministry of Agriculture approval under the Administrative Regulations on Pesticides and Chemical Fertilizer, while India operates under the Insecticides Act, 1968 with various registration types. The chapter examines Japan’s Pharmaceutical Affairs Law and the US system, where the Food and Drug Administration (FDA) and Environmental Protection Agency (EPA) share oversight under the Federal Food, Drug, and Cosmetic Act (FDC Act) and the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). It includes the EU process for the Inclusion of an Active Substance in Annex I of Directive 91/414/EEC.

Styles APA, Harvard, Vancouver, ISO, etc.

"Regulatory Bodies and Relevant Legislation." In Pharmaceutical, Biotechnology and Chemical Inventions, edited by Duncan Bucknell. Oxford University PressOxford, 2011. https://doi.org/10.1093/9780199289011.003.0066.

Texte intégral

Résumé :

Abstract This chapter explores the regulatory bodies and relevant legislation. It begins by looking at the Australian Therapeutic Goods Administration (TGA), which is a unit of the Australian Government’s Department of Health and Ageing. It is the body responsible for the registration and use of medicinal products and medical devices. The Therapeutic Goods Act 1989 (Cth) (‘TG Act’) defines medicinal products broadly to include goods that are represented in any way to be, or that are likely to be taken to be, for therapeutic use or for use as an ingredient or component in the manufacture of medicinal products or for use as a container for such goods. The chapter then considers the Food and Drug Act and the Patented Medicines (Notice of Compliance) Regulations (PMNOC Regulations) in Canada; the State Food and Drug Administration (SFDA) in China; the US Food and Drug Administration; and the Community Code in Europe. It also studies the regulatory bodies and relevant legislation in India, Japan, France, Germany, Italy, the Netherlands, and the United Kingdom.

Styles APA, Harvard, Vancouver, ISO, etc.

Lima de Magalhães, Jorge, Marcus Vinicius Santos do Carmo, and Zulmira Hartz. "Knowledge Management in Biotechnology Drugs in Brazil as a Case Study of the National Pharmaceuticals Laboratories." In Biotechnology. IGI Global, 2019. http://dx.doi.org/10.4018/978-1-5225-8903-7.ch061.

Texte intégral

Résumé :

The informational age in the twenty-first century is also known as the age of knowledge. The great differential of organizations has been the strategic innovation through the best way to manage the existing knowledge. The pharmaceutical area is one of the most intensive areas in research, development, and innovation. In this century, the discovery of new drugs and biotechnology drugs has revolutionized several treatments for human health. It is estimated that in 2017 the medical prescriptions of biotech drugs will exceed US $220 billion. It was identified that by the year 2019, several biotechnological patents will be expired in the world. New structures and strategic innovations in the scientific and technological environment of the Brazilian pharmaceutical area have occurred. There is a boom in investment opportunities in the industry through strategic innovation fostered by the updating of Brazilian legislation and investments by private companies. Knowledge management in biotechnological drugs has favored scientific, technological, and market growth in Brazilian organizations.

Styles APA, Harvard, Vancouver, ISO, etc.

Etty, Thijs. "Biotechnology." In The Year Book Of European Environmental Law. Oxford University PressOxford, 2005. http://dx.doi.org/10.1093/oso/9780199278787.003.0010.

Texte intégral

Résumé :

Abstract The survey year 2003 saw a storm of landmark events in the policy area of biotechnology law, both in the European Union (EU) and at the international level. The prediction in last year’s survey, that the transitory year 2002 would build up to a plethora of legislative and political developments in 2003, certainly was fulfilled. During the summer, the EU adopted long-awaited and fiercely debated new legislation on the authorization, marketing, traceability, and labelling of genetically modified (GM) food and feed products, and on the export and transboundary movements, and the traceability and labelling of genetically modified organisms (GM Os).This so-called ‘GM package’ has proved to be one of the most imperative and sensitive legislative dossiers of the EU in recent years, of course wrought with political compromises. Hence, it should come as no surprise that its final adoption has been heralded both as a victory and as a failure.

Styles APA, Harvard, Vancouver, ISO, etc.

"Opposition Proceedings." In Pharmaceutical, Biotechnology and Chemical Inventions, edited by Duncan Bucknell. Oxford University PressOxford, 2011. https://doi.org/10.1093/9780199289011.003.0039.

Texte intégral

Résumé :

Abstract This chapter focuses on opposition proceedings. An opposition is to be contrasted with a re-examination in that in an opposition the validity of the application or patent is contested between the patentee and a third party, before the patent office, but without the patent office reviewing patentability in its own right. The timing of opposition proceedings varies between those jurisdictions which have them. Australian and German oppositions occur pre-grant, whereas those before the European Patent Office occur after grant. India has both pre- and post-grant opposition proceedings available. The patent offices which administer oppositions have also set out a range of procedural rules to govern the various steps which must be taken in ascertaining the grounds of opposition, preparation and filing of evidence, and so on. Opposition proceedings are not available in Canada, China, France, Italy, Japan, the Netherlands, or the United States. Nevertheless, legislation has been proposed in the United States to establish opposition procedures.

Styles APA, Harvard, Vancouver, ISO, etc.

"Overview of Litigation1." In Pharmaceutical, Biotechnology and Chemical Inventions, edited by Duncan Bucknell. Oxford University PressOxford, 2011. https://doi.org/10.1093/9780199289011.003.0058.

Texte intégral

Résumé :

Abstract This chapter provides an overview of patent litigation or intellectual property litigation. In order to have standing before a court of any of the countries dealt with in this text, it is necessary to make a formal application. This document must set out certain information about the parties and the nature of the dispute to be resolved by the courts. The document may be referred to in different ways, such as a statement of claim or a complaint, and sometimes must be accompanied by evidence which substantiates the need to come before the court. In general, the court process is designed to identify precisely the facts and/or issues which are in dispute between the parties. This may involve a series of preliminary steps whereby each party is required to provide certain information, such as by discovery (or disclosure) of documents or questions and answers posed and answered by each side. Once the required information has been gathered, the parties must then prepare the evidence and summarize their legal arguments and any precedent or legislation on which they intend to rely. The extensive preparation of evidence theoretically enables the court hearing (or trial) to be confined to the facts and issues in dispute. The chapter also considers the role of technical experts and the provision for legal costs.

Styles APA, Harvard, Vancouver, ISO, etc.

Actes de conférences sur le sujet "Pharmaceutical biotechnology – Law and legislation"

Erimia, Cristina-Luiza. "FALSIFIED MEDICINES � A PROBLEM OF REGULATING THE PHARMACEUTICAL LEGISLATION BY STANDARDIZING THE EUROPEAN LAW." In 2nd International Multidisciplinary Scientific Conference on Social Sciences and Arts SGEM2015. Stef92 Technology, 2015. http://dx.doi.org/10.5593/sgemsocial2015/b21/s5.072.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Pashovska, Silvana, and Katerina Kareska. "ANALYSIS OF THE MEANING AND IMPACT OF SUBSIDIES ON THE DEVELOPMENT OF TOBACCO PRODUCTION IN MACEDONIA." In 1st International Symposium on Biotechnology. University of Kragujevac, Faculty of Agronomy, 2023. http://dx.doi.org/10.46793/sbt28.083p.

Texte intégral

Résumé :

With the payment of subsidies in agriculture, the Republic of North Macedonia remains consistent in supporting the development and advancement of the agricultural sector and specifically tobacco production as one of the main branches of the Macedonian economy. Of course, it is necessary to comply with the common agricultural policy of the European Union, which implies a change in domestic legislation. More specifically, it is a matter of passing three key laws for harmonizing national policies with EU agricultural policies, that is, the Law on Direct Payments, the Law on Rural Development and

Styles APA, Harvard, Vancouver, ISO, etc.

Акматова, Аманай Турсунбаевна. "LEGAL LIABILITY OF PHARMACISTS AND HEALTHCARE WORKERS FOR PROMOTING PHARMACEUTICAL DRUG ADDICTION: PROBLEMS OF IDENTIFICATION AND PROOF." In Социально-экономические и гуманитарные исследования в современном мире: сборник статей IV международной научной конференции (Тюмень, Июнь 2025). Crossref, 2025. https://doi.org/10.37539/250618.2025.96.49.006.

Texte intégral

Résumé :

В статье рассматриваются актуальные вопросы юридической ответственности фармацевтов и медицинских работников за содействие аптечной наркомании. Проанализированы проблемы, возникающие на этапе выявления и доказывания подобных преступлений, включая сложности правовой квалификации, недостатки нормативно-правового регулирования, а также пробелы в взаимодействии правоохранительных органов и системы здравоохранения. Автор подчёркивает необходимость усиления контроля за оборотом рецептурных препаратов, повышения уровня правосознания медицинского персонала и совершенствования механизмов привлечения к

Styles APA, Harvard, Vancouver, ISO, etc.

Акматова, Аманай Турсунбаевна. "ROLE OF LEGAL EDUCATIONIN THE FIGHT AGAINST ILLEGAL DRUG TRAFFICKINGTHROUGH PHARMACIES." In Science. Research. Practice (Наука. Исследования. Практика): сборник статей XCVI International scientific conference (Санкт-Петербург, Июнь 2025). Crossref, 2025. https://doi.org/10.37539/250620.2025.25.36.010.

Texte intégral

Résumé :

Незаконный оборот наркотических средств через легальные каналы, включая аптечные учреждения, представляет собой одну из наиболее тревожных форм латентной преступности в Кыргызской Республике. Особое значение приобретает проблема недостаточной правовой подготовки фармацевтических работников и низкого уровня правосознания среди участников оборота рецептурных препаратов. Настоящее исследование направлено на выявление взаимосвязи между уровнем юридического образования и эффективностью правоприменительной практики в борьбе с незаконным оборотом наркотиков. На основе анализа национального законодате

Styles APA, Harvard, Vancouver, ISO, etc.

Sovova, Olga. "ERA OF DIGITIZATION: RE-DESIGNING PRIVACY PROTECTION IN HEALTH CARE." In NORDSCI International Conference Proceedings. Saima Consult Ltd, 2019. http://dx.doi.org/10.32008/nordsci2019/b2/v2/31.

Texte intégral

Résumé :

The paper examines the issue arising when delivering healthcare in the modern information society. Throughout the past decade, the Internet has seen a significant rise of the "Web 2.0" trend, which carried on its wings a health industry trend often referred to as "Health 2.0" or "Medicine 2.0". More recently, we have also witnessed the crowning of concepts such as Health Social Media, eHealth and mHealth. European Union as well as the national states develop strategies implementing new technologies for personal and medical data sharing, including the prescription of medicals as well as their v

Styles APA, Harvard, Vancouver, ISO, etc.

Ghereg, Melania, Nina Chiorchina, Maria Tabăra, and Veaceslav Ghendov. "The initiation of sternbergia colchiciflora (amaryllidaceae) in tissue culture." In Scientific International Symposium “Advanced Biotechnologies - Achievements and Prospects” (VIth Edition). Institute of Genetics, Physiology and Plant Protection, 2022. http://dx.doi.org/10.53040/abap6.2022.54.

Texte intégral

Résumé :

One of the most threatened groups of higher vascular plants is the family Amaryllida-ceae. This family includes worldwide about 1100 species from 85 genera, which occur mostly in tropical and warm temperate regions of the world. It also represents one of the largest gro-ups of ornamental bulbiferous plants that are used in landscape design, particularly in stone and rock gardens. They are of high ornamental value, being used in ﬂoral arrangements, as cut ﬂowers and as potted plants for interior design, on balconies and terraces [2]. The genus Sternbergia belongs to the family Amaryllidaceae, a

Styles APA, Harvard, Vancouver, ISO, etc.

Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!